HYBRID EVENT: You can participate in person at Boston, Massachusetts, USA or Virtually from your home or work.
Obesity-related liver diseases

Obesity is a significant risk factor for liver diseases, particularly non-alcoholic fatty liver disease (NAFLD), which is characterized by excess fat accumulation in liver cells. NAFLD can progress to non-alcoholic steatohepatitis (NASH), liver fibrosis, and even cirrhosis if left untreated. The excess fat in obesity promotes inflammation and insulin resistance, further exacerbating liver damage. Weight loss, dietary modifications, and physical activity are critical in managing obesity-related liver conditions. Recognizing and addressing liver health in obesity is vital, as it can prevent severe liver complications and improve overall metabolic health, emphasizing the importance of comprehensive obesity management.

Committee Members
Speaker at World Obesity and Weight Management Congress 2026 - Russell Rising

Russell Rising

D & S Consulting Services Inc, United States
Speaker at World Obesity and Weight Management Congress 2026 - Robert Gabbay

Robert Gabbay

Harvard Medical School, United States
Speaker at World Obesity and Weight Management Congress 2026 - Hassan Massoud Heshmati

Hassan Massoud Heshmati

Endocrinology Metabolism Consulting, LLC, Hassan Heshmati and Valerie Shaw Endocrine Research, United States
Tags

Submit your abstract Today

Twitter XTwitter
Watsapp